最新 Form 144 申報
公司的高階主管、董事與其他關係人要賣出受限制股票或控制股份，而且三個月內預計賣出超過 5,000 股或 5 萬美元時，下單時要交 Form 144。它是預計賣出的通知；高階主管、董事實際賣出之後，會再申報 Form 4。13D、13G 與 Form 144 是什麼
Form 144 申報
由新到舊。有 Form 144/A 修正的申報只列修正後的那一份。
近 365 天的申報（依美東日期）。
本站的 Form 144 申報：2023/1/4 到 2026/10/2。
市值明顯填錯的申報不列在這裡，也不算進合計；公司的頁面照樣列出並加註。判斷方式是把市值除以股數，得到的每股價格遠高於這家公司在預計賣出日前後的 Form 4 成交價與 13F 持股的價格，就當成填錯。
- 申報份數
- 412
- 預計賣出市值
- $14.1 億
- 賣方
- 117
- 公司
- 37
- 依 10b5-1 計畫
- 219
| 公司 | 申報時間（美東） | 賣方 | 預計賣出股數 | 市值 | 預計賣出日 | 券商 | 原文 |
|---|---|---|---|---|---|---|---|
| CACCCredit Acceptance Corp | 2026/6/2616:36 ET | Elliott Nicholas J高階主管 | 2,306 | $145.3 萬 | 2026/6/2610b5-1 | Fidelity Brokerage Services LLC | SEC |
| LEGNLegend Biotech Corp | 2026/6/2615:23 ET | Huang Ying高階主管 · 董事 | 2,783 | $7.90 萬 | 2026/6/26 | Fidelity Brokerage Services LLC | SEC |
| ADPTAdaptive Biotechnologies Corp | 2026/6/2516:26 ET | Susan Bobulsky高階主管 | 5,000 | $9.67 萬 | 2026/6/2510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| ADPTAdaptive Biotechnologies Corp | 2026/6/2516:26 ET | Michelle Griffin董事 | 5.21 萬 | $100.7 萬 | 2026/6/2510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CACCCredit Acceptance Corp | 2026/6/2515:28 ET | Elliott Nicholas J高階主管 | 1,183 | $74.2 萬 | 2026/6/2510b5-1 | Fidelity Brokerage Services LLC | SEC |
| KRYSKrystal Biotech, Inc. | 2026/6/2510:03 ET | Thomas John Charles高階主管 | 1,000 | $34.7 萬 | 2026/6/2510b5-1 | Fidelity Brokerage Services LLC | SEC |
| CACCCredit Acceptance Corp | 2026/6/2416:17 ET | Elliott Nicholas J高階主管 | 3,487 | $209.6 萬 | 2026/6/2410b5-1 | Fidelity Brokerage Services LLC | SEC |
| AMPGAmpliTech Group, Inc. | 2026/6/2310:51 ET | Mazziota Daniel Richard董事 | 1.00 萬 | $8.16 萬 | 2026/6/23 | Charles Schwab Corp. | SEC |
| AMPGAmpliTech Group, Inc. | 2026/6/2309:18 ET | Mazziota Daniel Richard董事 | 7,157 | $6.05 萬 | 2026/6/22 | Charles Schwab Corp | SEC |
| ELVNEnliven Therapeutics, Inc. | 2026/6/2220:08 ET | The Biotech Growth Trust PLC股東 | 3.11 萬 | $143.1 萬 | 2026/6/22 | Jefferies LLC | SEC |
| IOTSamsara Inc. | 2026/6/2216:50 ET | Adam Eltoukhy高階主管 | 1,614 | $5.11 萬 | 2026/6/2210b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| RIOTRiot Platforms, Inc. | 2026/6/2216:48 ET | Jason LesCEO · 董事 | 25.0 萬 | $702.5 萬 | 2026/6/2210b5-1 | J.P. Morgan Securities LLC | SEC |
| LINDLindblad Expeditions Holdings, Inc. | 2026/6/1718:26 ET | Michael Elliott Bisnow董事 | 4.46 萬 | $107.0 萬 | 2026/6/17 | Goldman Sachs & Co. LLC | SEC |
| PTCTPTC Therapeutics, Inc. | 2026/6/1716:09 ET | Boulding Mark Elliott高階主管 | 1.05 萬 | $82.8 萬 | 2026/6/1710b5-1 | Fidelity Brokerage Services LLC | SEC |
| ARQTArcutis Biotherapeutics, Inc. | 2026/6/1716:08 ET | Howard Welgus董事 | 635 | $1.63 萬 | 2026/6/1710b5-1 | Merrill Lynch | SEC |
| CACCCredit Acceptance Corp | 2026/6/1712:52 ET | Elliott Nicholas J高階主管 | 3 | $1,733.55 | 2026/6/1710b5-1 | Fidelity Brokerage Services LLC | SEC |
| GWREGuidewire Software, Inc. | 2026/6/1619:55 ET | Jeffrey Elliott CooperChief Financial Officer | 2,594 | $30.8 萬 | 2026/6/16 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| ADPTAdaptive Biotechnologies Corp | 2026/6/1618:04 ET | Harlan Robins高階主管 | 6,160 | $10.6 萬 | 2026/6/1610b5-1 | Goldman Sachs & Co. LLC | SEC |
| CACCCredit Acceptance Corp | 2026/6/1616:21 ET | Elliott Nicholas J高階主管 | 36 | $2.08 萬 | 2026/6/1610b5-1 | Fidelity Brokerage Services LLC | SEC |
| ELVNEnliven Therapeutics, Inc. | 2026/6/1521:23 ET | The Biotech Growth Trust PLC股東 | 1.02 萬 | $43.4 萬 | 2026/6/15 | Themis Trading LLC | SEC |
| ADPTAdaptive Biotechnologies Corp | 2026/6/1518:10 ET | Harlan Robins高階主管 | 10.0 萬 | $174.6 萬 | 2026/6/1510b5-1 | Goldman Sachs & Co. LLC | SEC |
| IOTSamsara Inc. | 2026/6/1516:54 ET | Jonathan Chadwick董事 | 1.00 萬 | $33.7 萬 | 2026/6/1510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| CACCCredit Acceptance Corp | 2026/6/1516:22 ET | Elliott Nicholas J高階主管 | 16 | $9,201.06 | 2026/6/1510b5-1 | Fidelity Brokerage Services LLC | SEC |
| ARQTArcutis Biotherapeutics, Inc. | 2026/6/1516:11 ET | Sue-Jean Lin高階主管 | 4,946 | $12.1 萬 | 2026/6/1510b5-1 | Merrill Lynch | SEC |
| ARQTArcutis Biotherapeutics, Inc. | 2026/6/1516:11 ET | Howard Welgus董事 | 4,096 | $10.0 萬 | 2026/6/1510b5-1 | Merrill Lynch | SEC |
| IOTSamsara Inc. | 2026/6/1516:04 ET | Kirchhoff Benjamin Louis高階主管 | 2,549 | $8.60 萬 | 2026/6/1510b5-1 | Charles Schwab & Co., Inc. | SEC |
| MARMarriott International Inc | 2026/6/1215:53 ET | Brown William P高階主管 | 2,768 | $110.8 萬 | 2026/6/12 | Fidelity Brokerage Services LLC | SEC |
| PBYIPuma Biotechnology, Inc. | 2026/6/1210:39 ET | Senderowicz Adrian董事 | 2.70 萬 | $19.6 萬 | 2026/6/1210b5-1 | Fidelity Brokerage Services LLC | SEC |
| PBYIPuma Biotechnology, Inc. | 2026/6/1210:37 ET | Moyes Jay M董事 | 2.20 萬 | $16.0 萬 | 2026/6/1210b5-1 | Fidelity Brokerage Services LLC | SEC |
| PBYIPuma Biotechnology, Inc. | 2026/6/1210:33 ET | Dorval Allison董事 | 1.16 萬 | $8.43 萬 | 2026/6/1210b5-1 | Fidelity Brokerage Services LLC | SEC |
| PBYIPuma Biotechnology, Inc. | 2026/6/1210:23 ET | Stuglik Brian M董事 | 8,100 | $5.88 萬 | 2026/6/1210b5-1 | Fidelity Brokerage Services LLC | SEC |
| PBYIPuma Biotechnology, Inc. | 2026/6/1209:58 ET | Wilson Troy Edward董事 | 1.08 萬 | $7.84 萬 | 2026/6/1210b5-1 | Fidelity Brokerage Services LLC | SEC |
| ADPTAdaptive Biotechnologies Corp | 2026/6/1116:37 ET | Susan Bobulsky高階主管 | 5,000 | $8.54 萬 | 2026/6/1110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| AXSMAxsome Therapeutics, Inc. | 2026/6/918:01 ET | Herriot Tabuteau高階主管 | 4.97 萬 | $1,220 萬 | 2026/6/910b5-1 | Goldman Sachs & Co. LLC | SEC |
| CACCCredit Acceptance Corp | 2026/6/916:04 ET | Elliott Nicholas J高階主管 | 32 | $1.84 萬 | 2026/6/910b5-1 | Fidelity Brokerage Services LLC | SEC |
| CACCCredit Acceptance Corp | 2026/6/817:20 ET | Elliott Nicholas J高階主管 | 21 | $1.21 萬 | 2026/6/810b5-1 | Fidelity Brokerage Services LLC | SEC |
| IOTSamsara Inc. | 2026/6/817:15 ET | Andreessen Marc L持股 10% 以上股東 | 225.6 萬 | $7,898 萬 | 2026/6/8 | Raymond James & Associates | SEC |
| MARMarriott International Inc | 2026/6/516:12 ET | Lee Debra L前董事 | 3.27 萬 | $1,281 萬 | 2026/6/5 | Fidelity Brokerage Services LLC | SEC |
| ADPTAdaptive Biotechnologies Corp | 2026/6/416:34 ET | Susan Bobulsky高階主管 | 1.10 萬 | $17.6 萬 | 2026/6/410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| KRYSKrystal Biotech, Inc. | 2026/6/416:30 ET | Suma Krishnan董事 · 高階主管 · 持股 10% 以上股東 | 2.50 萬 | $754.5 萬 | 2026/6/410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| KRYSKrystal Biotech, Inc. | 2026/6/416:30 ET | Krish Krishnan董事 · 高階主管 · 持股 10% 以上股東 | 2.50 萬 | $754.5 萬 | 2026/6/410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| ADPTAdaptive Biotechnologies Corp | 2026/6/416:27 ET | Francis Lo高階主管 | 4.21 萬 | $67.3 萬 | 2026/6/410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| APTVAptiv PLC | 2026/6/313:24 ET | Liotine Joseph T.前高階主管 | 1.31 萬 | $98.3 萬 | 2026/6/3 | Fidelity Brokerage Services LLC | SEC |
| APTVAptiv PLC | 2026/6/215:16 ET | Liotine Joseph T.前高階主管 | 1.31 萬 | $93.3 萬 | 2026/6/2 | Fidelity Brokerage Services LLC | SEC |
| ASPIASP Isotopes Inc. | 2026/6/121:45 ET | Mann Paul Elliot董事 · 高階主管 | 25.1 萬 | $195.5 萬 | 2026/6/110b5-1 | Independent Trading Group (ITG) Inc. | SEC |
| CACCCredit Acceptance Corp | 2026/6/116:15 ET | Elliott Nicholas J高階主管 | 59 | $3.39 萬 | 2026/6/110b5-1 | Fidelity Brokerage Services LLC | SEC |
| VIRVir Biotechnology, Inc. | 2026/6/115:03 ET | Sabatini Brent高階主管 | 379 | $3,581.55 | 2026/6/110b5-1 | Fidelity Brokerage Services LLC | SEC |
| VIRVir Biotechnology, Inc. | 2026/6/113:04 ET | Napolitano Janet董事 | 3,200 | $3.02 萬 | 2026/6/110b5-1 | Fidelity Brokerage Services LLC | SEC |
| CACCCredit Acceptance Corp | 2026/5/2916:14 ET | Elliott Nicholas J高階主管 | 3,320 | $191.4 萬 | 2026/5/2910b5-1 | Fidelity Brokerage Services LLC | SEC |
| KRYSKrystal Biotech, Inc. | 2026/5/2610:30 ET | Thomas John Charles高階主管 | 642 | $19.4 萬 | 2026/5/2610b5-1 | Fidelity Brokerage Services LLC | SEC |